| Pharmaceutical active ingredients: |
| Mecamylamine Hydrochloride |
| Available forms, composition and doses of Inversine: |
| Tablets; Oral; Mecamylamine Hydrochloride 2.5 mg |
| Inversine medical category: |
| Human:Antihypertensive agentsNicotinic acetylcholine receptors antagonists |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| C02BB01 - Mecamylamine |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Layton BioscienceTargacept |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Mekamine | Mecamylamine | Unidentified Pharmaceutical Company |
| Mevasin | Mecamylamine | Unidentified Pharmaceutical Company |
| Mevasine | Mecamylamine | Unidentified Pharmaceutical Company |
| Revertina | Mecamylamine | Unidentified Pharmaceutical Company |
| Versamine | Mecamylamine | Unidentified Pharmaceutical Company |
| Somazon | Mecasermin | Unidentified Pharmaceutical Company |
| Increlex | Mecasermin rDNA origin | Baxter; Beaufour Ipsen; Tercica |
| Iplex | Mecasermin Rinfabate rDNA origin | Insmed |
| Azotoyperite | Mechlorethamine | Unidentified Pharmaceutical Company |
| Carolysine | Mechlorethamine | Unidentified Pharmaceutical Company |